| Analysis | Metabolite Name | Measured Value | Units | Sample | TREATMENT |
|---|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.6473 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7578 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.7725 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8331 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8409 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8852 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.8905 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9212 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9475 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9888 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9943 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 0.9961 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0039 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0109 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.043 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.0788 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1314 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1852 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.1871 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2272 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.2332 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.3318 | Peak area | Plasma | Saline |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4143 | Peak area | Plasma | Angiotensin II |
| Reversed phase NEGATIVE ION MODE | sphingomyelin (d18:1/18:1, d18:2/18:0) | 1.4501 | Peak area | Plasma | Saline |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|